Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Vered, Abitbol"'
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID
Autor:
Bénédicte Caron, Philippe Seksik, Anthony Buisson, Pauline Wils, Guillaume Savoye, Carmen Stefanescu, David Laharie, Lucas Guillo, Vered Abitbol, Joelle Bonnet, Romain Altwegg, Lucine Vuitton, Driffa Moussata, Arnaud Bourreille, Amélie Biron, Cyrielle Gilletta, Mathurin Fumery, Stephane Nahon, Stephane Nancey, Houda Camara, Laurent Peyrin-Biroulet
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: Several adalimumab preparations are now available for patients with inflammatory bowel disease (IBD). Comparative satisfaction and tolerability are unknown. Objectives: This study investigated IBD patient satisfaction with approved adalim
Externí odkaz:
https://doaj.org/article/7ca0c8a49c264203b43510c27bcad604
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 11 (2023)
The patent expiry of Humira in 2018 opened up the current European market to eight adalimumab biosimilars – (in alphabetical order) Amgevita, Amsparity, Hulio, Hukyndra, Hyrimoz, Idacio, Imraldi and Yuflyma – for the treatment of various immune
Externí odkaz:
https://doaj.org/article/43d7e9504aba45559133591af9ccb313
Autor:
Aurelien Amiot, Anne Bourrier, Jean-Marc Gornet, Olivier Dewit, Stephane Nancey, Romain Altwegg, Vered Abitbol, David Laharie, Catherine Reenaers, Charlotte Gagnière, Anthony Buisson, Maria Nachury, Stephanie Viennot, Lucine Vuitton, Carmen Stefanescu, Philippe Marteau, Guillaume Bouguen, Philippe Seksik
Publikováno v:
Infection Prevention in Practice, Vol 5, Iss 1, Pp 100267- (2023)
Summary: Background: Whether healthcare workers with inflammatory bowel disease (IBD) are at increased risk of Novel coronavirus disease (COVID-19) due to occupational exposure is unknown. Aim: To assess the risk of COVID-19 in healthcare workers wit
Externí odkaz:
https://doaj.org/article/77589efbbe5f4a03bea35dbb75ba4e58
Autor:
Solène Dermine, Maximilien Barret, Caroline Prieux, Sophie Ribière, Sarah Leblanc, Marion Dhooge, Catherine Brezault, Vered Abitbol, Benoit Terris, Frédéric Beuvon, Alexandre Rouquette, Bertrand Dousset, Sébastien Gaujoux, Philippe Soyer, Anthony Dohan, Jean-Emmanuel Bibault, Romain Coriat, Frédéric Prat, Stanislas Chaussade
Publikováno v:
Endoscopy International Open, Vol 06, Iss 12, Pp E1470-E1476 (2018)
Background The recent development of endoscopic resection for superficial gastrointestinal cancers could justify the need for a dedicated oncological multidisciplinary meeting (MDM). The aim of our study was to evaluate the impact of the dedicated MD
Externí odkaz:
https://doaj.org/article/22c54a3047ad4a1a821952a2c220eaab
Autor:
Rose Al Bacha, Yoram Bouhnik, Melanie Serrero, Jerome Filippi, Xavier Roblin, Anne Bourrier, Guillaume Bouguen, Denis Franchimont, Guillaume Savoye, Anthony Buisson, Edouard Louis, Stephane Nancey, Vered Abitbol, Jean-Marie Reimund, Olivier DeWit, Lucine Vuitton, Nicolas Mathieu, Laurent Peyrin-Biroulet, Cyrielle Gilletta, Matthieu Allez, Stephanie Viennot, Catherine Le Berre, David Laharie, Maria Nachury, Aurelien Amiot, Sara Tadbiri, Charlotte Gagniere, Jenny Tannoury, Benjamin Pariente, Pauline Wils, Carmen Stefanescu, Xavier Treton, Carole Martins, Mathieu Uzzan, Xavier Hébuterne, Nadia Arab, Virginie Cluzeau, Emilie Del Tedesco, Laurent Beaugerie, Philippe Seksik, Cecilia Landmann, Julien Kirchgesner, Harry Sokol, Laurent Siproudhis, Marie DeWitte, Catherine Reenaers, Gilles Boschetti, Claire Gay, Pauline Danion, Bernard Flourié, Georgia Malamut, Benedicte Caron, Olivier DeWitt, Sandie Pestour, Thomas Chateau, Camille Zallot, Jean-Marc Gornet, Clotilde Baudry, Arnaud Bourreille, Caroline Trang-Poisson, Nina Dib, Hedi Brixi, Guillaume Cadiot, Medina Boualit, Claire Painchart, Laurianne Plastaras, Romain Altwegg, Lucile Boivineau, Mathurin Fumery, Ludovic Caillo, Pauline Riviere, Florian Poullenot, Benoit Coffin, Henri Duboc, Stephane Nahon, Noemie Tavernier, Marion Simon, Baya Coulibaly, Morgane Amil, Duveau Nicolas, Sherine Khater, Mehdi Kaassis, Felix Goutorbe, Driffa Moussata, Laurence Picon
Publikováno v:
Digestive and Liver Disease
Digestive and Liver Disease, 2023, ⟨10.1016/j.dld.2023.05.008⟩
Digestive and Liver Disease, 2023, ⟨10.1016/j.dld.2023.05.008⟩
International audience; Background: In recent years, an increasing prevalence of obesity in inflammatory bowel disease (IBD) has been observed. However, only a few studies have focused on the impact of overweight and obesity on IBD-related disability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7063a4a36cbe10970704f3ac0d172dc9
https://doi.org/10.1016/j.dld.2023.05.008
https://doi.org/10.1016/j.dld.2023.05.008
Autor:
Yoram Bouhnik, Guillaume Pineton de Chambrun, Jérôme Lambert, Maria Nachury, Philippe Seksik, Romain Altwegg, Lucine Vuitton, Carmen Stefanescu, Stéphane Nancey, Alexandre Aubourg, Mélanie Serrero, Jérôme Filippi, Kristell Desseaux, Stéphanie Viennot, Vered Abitbol, Madina Boualit, Arnaud Bourreille, Cyrielle Giletta, Anthony Buisson, Xavier Roblin, Nina Dib, Georgia Malamut, Aurélien Amiot, Mathurin Fumery, Edouard Louis, Yasmine Elgharabawy, Laurent Peyrin-Biroulet, Jacques Moreau, Xavier Treton, Charlotte Mailhat, Justine Pollet, Carole Martins, Guillaume Savoye, Noémie Tavernier, Jean-Yves Mary, Magali Zappa, Claire Painchart
Publikováno v:
Clinical Gastroenterology and Hepatology
Clinical Gastroenterology and Hepatology, 2023, ⟨10.1016/j.cgh.2023.01.013⟩
Clinical Gastroenterology and Hepatology, 2023, ⟨10.1016/j.cgh.2023.01.013⟩
International audience; Background & aims: The management of intra-abdominal abscesses complicating Crohn's disease (CD) is challenging and surgery with delayed intestinal resection is often recommended. The aims of this study were to estimate the su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd1a9756f81aef8fa395ee2f80cb15dd
https://hal-u-picardie.archives-ouvertes.fr/hal-03981017
https://hal-u-picardie.archives-ouvertes.fr/hal-03981017
Autor:
Cécile Audrey Durel, Guillaume Moulis, Mathurin Fumery, Vered Abitbol, Stéphane Nancey, Groupe français d’étude des vascularites, Marie-Christine Martinez Vinson, Khalil El Karoui, Viviane Queyrel-Moranne, Christian Agard, Alexis Régent, Stéphane Koch, Benjamin Terrier, Didier Ducloux, Anne-Gaëlle Kervegant, Laurent Peyrin Biroulet, David Laharie, Anne Bourrier, Michael T. Collins, Lucine Vuitton, Cédric Rafat, Loïc Guillevin, Romain Paule, Mickaela Voicu, Camille Rasmussen, François Aubin, François Maurier, Caroline Morbieu, Nizar Joher, Tali Anne Szwebel, Bénédicte Pigneur
Publikováno v:
Rheumatology. 61:1957-1965
Objective The association of IgA vasculitis (IgAV) and IBD is rarely described, mainly during anti-TNF-α therapy. We aimed to describe the association of IgAV and IBD. Methods We retrospectively analysed the association of IgAV and IBD through the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb034b32dd494cae9be4a2f413eb75d2
https://doi.org/10.1093/rheumatology/keab662
https://doi.org/10.1093/rheumatology/keab662
Autor:
Mathurin Fumery, Jérôme Filippi, Vered Abitbol, Amélie Biron, David Laharie, Melanie Serrero, Romain Altwegg, Yoram Bouhnik, Laurent Peyrin‐Biroulet, Cyrielle Gilletta, Xavier Roblin, Guillaume Pineton de Chambrun, Lucine Vuitton, Anne Bourrier, Stephane Nancey, Jean‐Marc Gornet, Stephane Nahon, Guillaume Bouguen, Stephanie Viennot, Maria Nachury, Aurelien Amiot, Franck Brazier, Clara Yzet, Xavier Hebuterne, Guillaume Cadiot, Hedia Brixi, Pauline Rivière, Florian Poullenot, Xavier Treton, Carmen Stefanescu, Camille Zallot, Laurent Beaugerie, Philippe Seksik, Harry Sokol, Julien Kirchgesner, Gilles Boschetti, Bernard Flourié, Claire Gay, Pauline Danion, Chloe Venturin, Matthieu Allez, Clotilde Baudry, Benjamin Pariente, Pauline Wils, Charlotte Gagnière, Jenny Tannoury
Publikováno v:
Alimentary Pharmacology and Therapeuthics
Alimentary Pharmacology and Therapeuthics, 2021, 54 (7), pp.944-951. ⟨10.1111/apt.16544⟩
Alimentary Pharmacology and Therapeuthics, 2021, 54 (7), pp.944-951. ⟨10.1111/apt.16544⟩
International audience; Background Phase III trials have demonstrated the efficacy and safety of ustekinumab in ulcerative colitis (UC), but few real-life long-term data are currently available. Aims To assess the real-world effectiveness and safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1300d335548f69e1913af935909c768f
https://doi.org/10.1111/apt.16544
https://doi.org/10.1111/apt.16544
Autor:
Aurelien Amiot, Philippe Seksik, Jean-Marie Reimund, Maria Nachury, Romain Altwegg, Arnaud Bourreille, Stephanie Viennot, Mathurin Fumery, Xavier Roblin, Melanie Serrero, Matthieu Allez, Claire Painchart, Elise Chanteloup, Lucine Vuitton, Ginette Fotsing, Anthony Buisson, Baya Coulibaly, Stephane Nancey, Cyrielle Gilletta, Laurianne Plastaras, Vered Abitbol, Lucas Guillo, Marion Simon, Stephane Nahon, David Laharie, Laurent Peyrin-Biroulet, Guillaume Bouguen, Charlotte Gagniere, Pauline Wils, Yoram Bouhnik, Carmen Stefanescu, Xavier Treton, Carole Martins, Mathieu Uzzan, Emilie Del Tedesco, Laurent Beaugerie, Anne Bourrier, Cecilia Landmann, Julien Kirchgesner, Harry Sokol, Gilles Boschetti, Claire Gay, Pauline Danion, Bernard Flourié, Georgia Malamut, Benedicte Caron, Camille Zallot, Jean-Marc Gornet, Clotilde Baudry, Caroline Trang-Poisson, Medina Boualit, Lucile Boivineau, Pauline Riviere, Florian Poullenot, Benoit Coffin, Henri Duboc
Publikováno v:
Digestive and Liver Disease
Digestive and Liver Disease, 2022, 54 (10), pp.1350-1357. ⟨10.1016/j.dld.2022.04.011⟩
Digestive and Liver Disease, WB Saunders, 2022, ⟨10.1016/j.dld.2022.04.011⟩
Digestive and Liver Disease, Elsevier, 2022, ⟨10.1016/j.dld.2022.04.011⟩
Digestive and Liver Disease, 2022, 54 (10), pp.1350-1357. ⟨10.1016/j.dld.2022.04.011⟩
Digestive and Liver Disease, WB Saunders, 2022, ⟨10.1016/j.dld.2022.04.011⟩
Digestive and Liver Disease, Elsevier, 2022, ⟨10.1016/j.dld.2022.04.011⟩
International audience; BACKGROUND: The exact rate of contraindications to anti-TNF therapy and physician perspectives on treatment choices facing to anti-TNF contraindication, are poorly reported. METHODS: A two-week cross-sectional study was conduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8429c1ecf8f8517bf68085551aa70d7
https://hal.science/hal-03690498/document
https://hal.science/hal-03690498/document
Autor:
Aurelien Amiot, David Laharie, Georgia Malamut, Melanie Serrero, Florian Poullenot, Laurent Peyrin-Biroulet, Arnaud Bourreille, Lucine Vuitton, Guillaume Bouguen, Vered Abitbol, Amelie Biron, Anne Bourrier, Ludovic Caillo, Mathurin Fumery, Cyrielle Gilletta, Laurianne Plastaras, Marion Simon, Stephanie Viennot, Philippe Seksik, Alain Attar, Anthony Buisson, Benedicte Caron, Maeva Charkaoui, Jean-Marc Gornet, Lucas Guillo, Catherine Le Berre, Edouard Louis, Nicolas Mathieu, Maria Nachury, Stephane Nancey, Stephane Paul, Catherine Reenaers, Xavier Treton, Mathieu Uzzan, Pauline Wils
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 54(9)
There is no consensus on the management of immune checkpoint inhibitor (ICI) for treating cancer in patients with pre-existing inflammatory bowel disease (IBD). The Groupe d'Étude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05ffe6a141c3a5e71fe602de35b93b72
https://pubmed.ncbi.nlm.nih.gov/35842365
https://pubmed.ncbi.nlm.nih.gov/35842365